This too shall pass: Standardized Gastrografin protocol for partial small bowel obstruction

Area of Science:

• Gastroenterology
• Surgical Management
• Radiology

Background:

• Partial small bowel obstruction is a common surgical admission with varied management strategies.
• Diatrizoate (Gastrografin) shows promise as a diagnostic and therapeutic agent, potentially reducing surgical intervention.
• Limited data exists on Gastrografin's use in community healthcare settings.

Purpose of the Study:

• To evaluate the effectiveness of a standardized Gastrografin administration protocol for partial small bowel obstruction.
• To determine if this protocol reduces surgical intervention and length of hospital stay in a community setting.
• To assess Gastrografin's utility beyond controlled clinical trials.

Main Methods:

• Retrospective review of 1302 patients with partial small bowel obstruction across two hospitals.
• Comparison of patients managed with a Gastrografin protocol versus standard care.
• Exclusion criteria included recent bowel surgery or age under 18.
• Statistical analysis using Fisher's Exact test and Mann-Whitney U test.

Main Results:

• Patients on the Gastrografin protocol experienced shorter hospital stays (4.9 vs. 6.0 days, p < 0.001).
• The protocol significantly lowered surgery rates (2% vs. 16%, p < 0.001).
• Readmission rates for partial small bowel obstruction were similar between groups (8% vs. 5%, p = 0.26).

Conclusions:

• A Gastrografin protocol effectively manages partial small bowel obstruction in a community setting.
• This approach decreases the need for surgery and shortens hospital length of stay.
• Gastrografin administration protocol is a valuable tool for community-based surgical services.